Climb Biotherapeutics, Inc. (CLYM) at a glance

Climb Biotherapeutics, Inc. (CLYM) is a small-cap Healthcare company. It trades at $14.68, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Momentum (71/100) and its weakest is Income (40/100).

Price
$14.68
Market cap
$655.1M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.54 to $18.33
Vestovix Score53/ 100How this works
Value
50
Growth
50
Income
40
Safety
62
Momentum
71

Other Healthcare stocks

See all